Download pdf file (78KB)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Medicines under additional monitoring<\/p>\n","protected":false},"author":173,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[451],"tags":[],"class_list":["post-29122","post","type-post","status-publish","format-standard","hentry","category-pharmacovigilance","entry"],"acf":[],"yoast_head":"\n
Medicines under additional monitoring | SFEE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicines under additional monitoring | SFEE\" \/>\n<meta property=\"og:description\" content=\"Medicines under additional monitoring\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\" \/>\n<meta property=\"og:site_name\" content=\"SFEE\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/sfeegreece\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-04-25T14:32:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-06-19T09:38:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sfee.gr\/preview.jpg\" \/>\n<meta name=\"author\" content=\"karkanis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sfeegreece\" \/>\n<meta name=\"twitter:site\" content=\"@sfeegreece\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"karkanis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\"},\"author\":{\"name\":\"karkanis\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc\"},\"headline\":\"Medicines under additional monitoring\",\"datePublished\":\"2013-04-25T14:32:43+00:00\",\"dateModified\":\"2018-06-19T09:38:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\"},\"wordCount\":9,\"articleSection\":[\"Pharmacovigilance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\",\"url\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\",\"name\":\"Medicines under additional monitoring | SFEE\",\"isPartOf\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/#website\"},\"datePublished\":\"2013-04-25T14:32:43+00:00\",\"dateModified\":\"2018-06-19T09:38:47+00:00\",\"author\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae\",\"item\":\"https:\/\/www.sfee.gr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medicines under additional monitoring\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#website\",\"url\":\"https:\/\/www.sfee.gr\/en\/\",\"name\":\"\u03a3\u03a6\u0395\u0395\",\"description\":\"The Hellenic Association of Pharmaceutical Companies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sfee.gr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc\",\"name\":\"karkanis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d31bae8ebb626fcfb2ed2d04d25d51ba18dd1d4810c09c69ac3048c652dc1987?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d31bae8ebb626fcfb2ed2d04d25d51ba18dd1d4810c09c69ac3048c652dc1987?s=96&d=mm&r=g\",\"caption\":\"karkanis\"},\"url\":\"https:\/\/www.sfee.gr\/en\/author\/pkarkanis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medicines under additional monitoring | SFEE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/","og_locale":"en_US","og_type":"article","og_title":"Medicines under additional monitoring | SFEE","og_description":"Medicines under additional monitoring","og_url":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/","og_site_name":"SFEE","article_publisher":"https:\/\/www.facebook.com\/sfeegreece\/","article_published_time":"2013-04-25T14:32:43+00:00","article_modified_time":"2018-06-19T09:38:47+00:00","og_image":[{"url":"https:\/\/www.sfee.gr\/preview.jpg","type":"","width":"","height":""}],"author":"karkanis","twitter_card":"summary_large_image","twitter_creator":"@sfeegreece","twitter_site":"@sfeegreece","twitter_misc":{"Written by":"karkanis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#article","isPartOf":{"@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/"},"author":{"name":"karkanis","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc"},"headline":"Medicines under additional monitoring","datePublished":"2013-04-25T14:32:43+00:00","dateModified":"2018-06-19T09:38:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/"},"wordCount":9,"articleSection":["Pharmacovigilance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/","url":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/","name":"Medicines under additional monitoring | SFEE","isPartOf":{"@id":"https:\/\/www.sfee.gr\/en\/#website"},"datePublished":"2013-04-25T14:32:43+00:00","dateModified":"2018-06-19T09:38:47+00:00","author":{"@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc"},"breadcrumb":{"@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sfee.gr\/en\/medicines-under-additional-monitoring\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0391\u03c1\u03c7\u03b9\u03ba\u03ae","item":"https:\/\/www.sfee.gr\/en\/"},{"@type":"ListItem","position":2,"name":"Medicines under additional monitoring"}]},{"@type":"WebSite","@id":"https:\/\/www.sfee.gr\/en\/#website","url":"https:\/\/www.sfee.gr\/en\/","name":"\u03a3\u03a6\u0395\u0395","description":"The Hellenic Association of Pharmaceutical Companies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sfee.gr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/58814d28eb7e478379729112da6ff9cc","name":"karkanis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sfee.gr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d31bae8ebb626fcfb2ed2d04d25d51ba18dd1d4810c09c69ac3048c652dc1987?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d31bae8ebb626fcfb2ed2d04d25d51ba18dd1d4810c09c69ac3048c652dc1987?s=96&d=mm&r=g","caption":"karkanis"},"url":"https:\/\/www.sfee.gr\/en\/author\/pkarkanis\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts\/29122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/users\/173"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/comments?post=29122"}],"version-history":[{"count":0,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/posts\/29122\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/media?parent=29122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/categories?post=29122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sfee.gr\/en\/wp-json\/wp\/v2\/tags?post=29122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}